Simcyp

This week, Certara, a software and scientific consulting vendor, launched the Cardiac Safety Simulator, a tool that lets pharmaceutical companies test the toxicity of potential drug candidate on the heart using an in silico model of ventricular cells and determine safe dosage reg

GenBank 194.0 is now available via FTP from the National Center for Biotechnology Information.

Simcyp, a division of Certara, said this week that it has entered into a Cooperative Research and Development Agreement with the US Food and Drug Administration to further develop the Simcyp Dog model for the evaluation of drug products intended for use in different canine breeds

Researchers from the Victorian Bioinformatics Consortium have released version 2.2.4 of the Velvet Optimiser, which includes a several bug fixes.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.